Top

Published in:

01-02-2016 | Case Report

Pulmonary scedosporiosis mimicking aspergilloma in an immunocompetent host: a case report and review of the literature

Authors: Fasih Ur Rahman, Muhammad Irfan, Naima Fasih, Kauser Jabeen, Hasanat Sharif

Published in: Infection | Issue 1/2016

Abstract

A case of localized lung scedosporiosis is reported here that mimicked aspergilloma in an immunocompetent host. Through this case the importance of considering Scedosporium spp. in differential diagnosis of locally invasive lung infections and fungal ball is highlighted. As it is difficult to differentiate Scedosporium from Aspergillus on clinical grounds, microscopy, radiology and histopathology, this case is further emphasizing the significance of the definitive etiological characterization of Scedosporium through culture or molecular diagnostic tools. Accurate identification of Scedosporium, surgical resection and high-dose voriconazole has been associated with favorable outcome in most reported cases of scedosporiosis.

Cortez KJ, Roilides E, Quiroz-Telles F, Meletiadis J, Antachopoulos. Infections caused by Scedosporium spp. Clin Microbiol Rev. 2008;21:157–97.PubMedCentralCrossRefPubMed

Koga T, Kitajima T, Tanaka R, Hirokawa M, Ichiki M, Rikimaru T, et al. Chronic pulmonary scedosporiosis simulating aspergillosis. Respirology. 2005;10:682–4.CrossRefPubMed

Al Refaï M, Duhamel C, Le Rochais JP, Icard P. Lung scedosporiosis: a differential diagnosis of aspergillosis. Eur J Cardiothorac Surg. 2002;21:938–9.CrossRefPubMed

Horré R, Jovanić B, Marklein G, Schumacher G, Friedrichs N, Neuhaus T, de Hoog GS. Fatal pulmonary scedosporiosis. Mycoses. 2003;46:418–21.CrossRefPubMed

Larone DH. Medically important fungi. 4th ed. Washington, DC: ASM Press; 2002.

Girmenia C, Luzi G, Monaco M, Martino P. Use of voriconazole in treatment of Scedosporium apiospermum infection: case report. J Clin Microbiol. 1998;36:1436–8.PubMedCentralPubMed

Troke P, Aguirrebengoa K, Arteaga C, Ellis D, Heath CH, Lutsar I, et al. Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients. Antimicrob Agents Chemother. 2008;52:1743–50.PubMedCentralCrossRefPubMed

Rodriguez-Tudela JL, Berenguer J, Guarro J, Kantarcioglu AS, Horre R, de Hoog GS, et al. Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases. Med Mycol. 2009;47:359–70.CrossRefPubMed

Severo LC, Oliveira F de M, Irion K. Respiratory tract intracavitary colonization due to Scedosporium apiospermum: report of four cases. Rev Inst Med Trop Sao Paulo. 2004;46:43–6.

10.

Ogata R, Hagiwara E, Shiihara J, Ogura T, Takahashi H, Kamei K. A case of lung scedosporiosis successfully treated with monitoring of plasma voriconazole concentration level. Nihon Kokyuki Gakkai Zasshi. 2011;49:388–92.PubMed

11.

Severo LC, Londero AT, Picon PD, Rizzon CFC, Tarasconi JC. Petriellidium boydii fungus ball in a patient with active tuberculosis. Mycopathologia. 1982;77:15–7.CrossRefPubMed

12.

Severo LC, Porto NS, Londero AT. Pulmonary scedosporiosis. Rev Inst Med Trop Sao Paulo. 1998;40:241–3.CrossRefPubMed

13.

Soman R, Mahashur AA, Naphade D, Rodrigues C, Bhaduri A, et al. Pseudallescheria boydii lung infection in an immunocompetent adult, difficulties in diagnosis and management. J Assoc Physicians India. 2010;58:633–4.PubMed

14.

Abgrall S, Pizzocolo C, Bouges-Michel C, Martinod E, Martin A, Brauner M, et al. Scedosporium apiospermum lung infection with fatal subsequent postoperative outcome in an immunocompetent host. Clin Infect Dis. 2007;45:524–5.CrossRefPubMed

15.

Deloach ED, DiBenedetto RJ, Hitch WS, Russell P. Pulmonary infection with Petriellidium boydii. South Med J. 1979;72:479–81.CrossRefPubMed

16.

Ceccarelli L, Calisti G, Delle Rose D, Ricciardi A, Maffongelli G, Sordillo P, et al. Dapsone hypersensitivity syndrome complicated by Scedosporium apiospermum pneumonia in an immunocompetent patient. Infection. 2012;40:459–62.CrossRefPubMed

17.

Chen TC, Ho MW, Chien WC, Lin HH. Disseminated Scedosporium apiospermum infection in a near-drowning patient. J Formos Med Assoc. 2015. doi:10.1016/j.jfma.2015.02.007.

18.

Agatha D, Krishnan KU, Dillirani VA, Selvi R. Invasive lung infection by Scedosporium apiospermum in an immunocompetent individual. Indian J Pathol Microbiol. 2014;57:635–7.CrossRefPubMed

19.

Castón JJ, Linares MJ, Rivero A, Casal M, Torre-Cisneros J. Clinical differences between invasive pulmonary infection by Scedosporium apiospermum and invasive pulmonary aspergillosis. Mycoses. 2011;54:e468–73.CrossRefPubMed

20.

Kantarcioglu AS, de Hoog GS, Guarro J. Clinical characteristic and epidemiology of pulmonary pseudallescheriasis. Rev Iberoam Micol. 2012;29:1–13.CrossRefPubMed

21.

Durand CM, Durand DJ, Lee R, Ray SC, Neofytos D. A 61 year-old female with a prior history of tuberculosis presenting with hemoptysis. Clin Infect Dis. 2011;52:910 (957–9).CrossRefPubMed

22.

Tekavec J, Mlinarić-Missoni E, Babic-Vazic V. Pulmonary tuberculosis associated with invasive pseudallescheriasis. Chest. 1997;111:508–11.CrossRefPubMed

23.

Nakadate T, Nakamura Y, Yamauchii K, Endo S. Two cases of severe pneumonia after the 2011 Great East Japan Earthquake. Western Pac Surveill Response J. 2012;3:67–70.PubMedCentralPubMed

Title: Pulmonary scedosporiosis mimicking aspergilloma in an immunocompetent host: a case report and review of the literature
Authors: Fasih Ur Rahman
Muhammad Irfan
Naima Fasih
Kauser Jabeen
Hasanat Sharif
Publication date: 01-02-2016
Publisher: Springer Berlin Heidelberg
Published in: Infection / Issue 1/2016
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI: https://doi.org/10.1007/s15010-015-0840-4

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Pulmonary scedosporiosis mimicking aspergilloma in an immunocompetent host: a case report and review of the literature

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2016

Hypertriglyceridemia: a possible diagnostic marker of disease severity in visceral leishmaniasis

A novel duplex real-time PCR permits simultaneous detection and differentiation of Borrelia miyamotoi and Borrelia burgdorferi sensu lato

Comment on: “antibiotic use varies substantially among adults: a cross-national study from five European countries in the ARITMO project”

Dual treatment of acute HCV infection in HIV co-infection: influence of HCV genotype upon treatment outcome

High seroprevalence of HCV in the Abruzzo Region, Italy: results on a large sample from opt-out pre-surgical screening

Rapid regression of Kaposi’s sarcoma of the hard palate under therapy with boosted elvitegravir-containing fixdose antiretroviral combination therapy

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page